-
Advertorial
-
FOCUS
-
Guide
-
Lifestyle
-
Tech and Vogue
-
TechandScience
-
CHTF Special
-
Nanshan
-
Futian Today
-
Hit Bravo
-
Special Report
-
Junior Journalist Program
-
World Economy
-
Opinion
-
Diversions
-
Hotels
-
Movies
-
People
-
Person of the week
-
Weekend
-
Photo Highlights
-
Currency Focus
-
Kaleidoscope
-
Tech and Science
-
News Picks
-
Yes Teens
-
Budding Writers
-
Fun
-
Campus
-
Glamour
-
News
-
Digital Paper
-
Food drink
-
Majors_Forum
-
Speak Shenzhen
-
Shopping
-
Business_Markets
-
Restaurants
-
Travel
-
Investment
-
Hotels
-
Yearend Review
-
World
-
Sports
-
Entertainment
-
QINGDAO TODAY
-
In depth
-
Leisure Highlights
-
Markets
-
Business
-
Culture
-
China
-
Shenzhen
-
Important news
在线翻译:
szdaily -> Business_Markets -> 
Alibaba to inject pharmacy assets into listed unit
    2018-05-30  08:53    Shenzhen Daily

E-COMMERCE giant Alibaba Group Holding Ltd. will inject some of its online pharmacy business into a listed unit in a deal valued at HK$10.6 billion (US$1.35 billion), the firm said in a statement yesterday.

Alibaba Health Information Technology Ltd. will buy Ali JK Nutritional Products Holding Ltd., which controls sales of medical devices, health-care products, adult products and health-care services on Alibaba’s Tmall platform.

The deal will see parent Alibaba receive newly issued shares in Ali Health, taking its economic interest in the firm to 56.2 percent from 48.1 percent currently. Alibaba will also have a 67.5-percent voting interest in Ali Health after the deal.

The deal should bolster business for Ali Health amid a broader push into a fast-growing health-care technology market by other firms in China, such as Tencent Holdings-backed WeDoctor and recently listed Ping An Healthcare.

Alibaba CEO Daniel Zhang said in a statement that health care was a “strategically important” business area for the firm and that the deal would help turn Ali Health into the country’s “best health-care ecosystem.”

Ali Health’s CEO added that the deal would help the firm expand by adding new categories to its offering.

Chinese health-care spending is set to hit US$1 trillion by 2020, up from US$357 billion in 2011, according to consultancy McKinsey & Co., with technology firms increasingly looking to break into a growing private health-care market.

(SD-Agencies)

深圳报业集团版权所有, 未经授权禁止复制; Copyright 2010, All Rights Reserved.
Shenzhen Daily E-mail:szdaily@szszd.com.cn